Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 32 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors				Phase III				CHLA-HEAD-START-III CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
	SCRT Vs Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumours				Phase III				SCRT Trial NCT00517959
	A Phase I/II Study of the Photon Radiosurgery System				Phase II, Phase I				CNS 0201 NCT00179907
	A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors				Phase II, Phase I				SUN08-01 NCT00704054
	Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors				Phase II, Phase I				CHNMC-07053 07053, CA180 121, NCT00788125
	Antineoplaston Therapy in Treating Children With Brain Tumors				Phase II				BC-BT-10 NCT00003458
	Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors				Phase II				BC-BT-22 NCT00003476
	Antineoplaston Therapy in Treating Children With Visual Pathway Glioma				Phase II				BC-BT-23 NCT00003477
	Radiation Therapy in Treating Young Patients With Gliomas				Phase II				COG-ACNS0221 ACNS0221, CIRB-05016, NCT00238264
	Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer				Phase II				DFCI-04343 04-343, NCT00357500


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute